Biological therapy in rheumatoid arthritis – Notes for the pharmacist

  • Lynn Lambert Amayeza Information Centre
Keywords: rheumatoid arthritis, biological therapy

Abstract

Progress in understanding the molecular biology of rheumatoid arthritis has led to the development of targeted therapies designed to ameliorate this disabling disease and improve patient outcomes. Biologic-based therapies are being developed to target specific cytokines in the inflammatory pathway, such as tumour necrosis factor (TNF), T-lymphocytes, B-lymphocytes and interleukin-6 (IL-6). An overview of biological therapies for rheumatoid arthritis forms the basis of this article.

Author Biography

Lynn Lambert, Amayeza Information Centre

Amayeza Information Services

Published
2019-09-05
Section
Reviews